Peter D. Beitsch
Dallas Surgical Group · 209 works · 16,299 citations · h-index 51
Top works
- The Sentinel Node in Breast Cancer — A Multicenter Validation Study
- Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
- Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
- Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011
- Circulating Tumor Cells in Patients with Breast Cancer Dormancy
- Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
- HER-2 gene amplification can be acquired as breast cancer progresses
- Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
- Gender-Related Differences in Outcome for Melanoma Patients
- Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.
- Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial
- Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
- Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection
- Lessons learned from the Sunbelt Melanoma Trial
- uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues
- Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011
- First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity
- Three‐year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI)
- Sentinel Node Skills Verification and Surgeon Performance